Krsnaa Diagnostics

Krsnaa Diagnostics

Year of investment2015

A Pan-India Diagnostics Company

Krsnaa Diagnostics, a NABL and NABH accredited diagnostics chain, is the largest Pan-India diagnostics (radiology & pathology) service provider and is also the largest PPP player in diagnostics healthcare in India. It offers regular MRI, CT Scan, radiology and pathology services to ultramodern DEXA scans & ARCHITECT based pathology services.

ESG & Impact

It is the largest player in Public-Private Partnership in CT, MRI imaging, tele-radiology and pathology across states across India – 70 centres and growing, catering to lower income population in metros and lower tier towns in India.

Almost 90% of the patients coming to the hospitals are under various government sponsored schemes catering to the lower strata of the population. The aim is to improve on this metric year on year by adding new centres in the network.

The company clocks ~1 Mn+ CT/MRI scans per year at ~30-40% cheaper rates than any other private diagnostics network player and operates 1000+ X-Ray centers, 35+ MRI centers and 800+ pathology collection centers. The Company partners with state government run hospitals, private medical colleges and large private hospitals to offer such services at highly attractive, affordable prices. This disruptive model increases access to MRI and CT Scan services in particular and to all segments of society including lower and middle income groups. It has also launched India’s largest tele – radiology NABH certified platform in India, the data generated is being used by companies to improve its AI engine in Imaging across various modalities of imaging.

It has become the 3rd largest Covid-testing and communicable diseases’ testing provider in India, providing affordable diagnostics scans and has also become preferred partner for most state governments in India. The company also serves as covid and communicable diseases’ testing centres in many states of the country. It has launched India’s 1st Covid Testing Mobile Unit (Covid Bus) to increase testing penetration during difficult times.  

The Managing Director of the company is a woman – Ms. Pallavi Jain.